Exelixis Statistics
NASDAQ: EXELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
64.63-1.20 (-1.82%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Exelixis by the numbers
Exelixis has a market capitalization of $15.77 billion based on 244.01M shares outstanding. Its trailing P/E ratio is 19.4, below the 5-company peer median of 26.6, and its forward P/E is 15.1. The stock trades 2.3% above its 50-day average and 22.3% above its 200-day average.
Average daily trading volume is 2.45M shares, or about $158.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EXEL valuation vs. peer median
| Metric | EXEL | Peer median | Difference |
|---|---|---|---|
| Market cap | $15.77B | $10.44B | +51% |
| P/E (TTM) | 19.4 | 26.6 | -27% |
| Forward P/E | 15.1 | 25.0 | -39% |
| Avg. volume | 2.45M | 1.25M | +95% |
Peer median across 8 companies: NBIX, BNTX, TECH, RGEN, HALO, QGEN, KYMR, KRYS.
Valuation
- Market cap
- $15.77B
- P/E (TTM)
- 19.35
- Forward P/E
- 15.12
- Price / sales (latest FY)
- 6.80
- EPS (TTM)
- $3.34
- Shares outstanding
- 244.01M
Price and trading
- Previous close
- 65.83
- Open
- 65.90
- Day range
- 64.45 – 66.94
- 52-week range
- 39.71 – 73.69
- 52-week change
- +52.03%
- Beta
- —
- Volume
- 2.19M
- Average volume
- 2.45M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 15.77B
- Pe
- 19.35
- Forward Pe
- 15.12
- Eps
- 3.34
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 73.69
- Week52 Low
- 39.71
- Avg Volume
- 2.45M
- Shares Outstanding
- 244.01M
- Ma50
- 63.20
- Ma200
- 52.86
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -12.29%
- Pct From52w Low
- 62.75%